Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
Loading...
Files
Accepted Version
Date
2020-04-24
Authors
Klimek, L.
Jutel, M.
Akdis, C.
Bousquet, J.
Akdis, M.
Bachert, C.
Agache, I.
Ansotegui, I.
Bedbrook, A.
Bosnic-Anticevich, S.
Journal Title
Journal ISSN
Volume Title
Publisher
John Wiley & Sons, Inc.
Published Version
Abstract
The current COVID-19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on immunological effects on the diseased patient.
Description
Keywords
COVID-19 , Allergen-specific immunotherapy , AIT
Citation
Klimek, L., Jutel, M., Akdis, C., Bousquet, J., Akdis, M., Bachert, C., Agache, I., Ansotegui, I., Bedbrook, A., Bosnic-Anticevich, S., Canonica, G. W., Chivato, T., Cruz, A. A., Czarlewski, W., Giacco, S. D., Du, H., Fonseca, J. A., Gao, Y., Haahtela, T., Hoffmann-Sommergruber, K., Ivancevich, J. C., Khaltaev, N., Knol, E. F., Kuna, P., Larenas-Linnemann, D., Melen, E., Mullol, J., Naclerio, R., Ohta, K., Okamoto, Y., O'Mahony, L., Onorato, G. L., Papadopoulos, N. G., Pawankar, R., Pfaar, O., Samolinski, B., Schwarze, J., Toppila-Salmi, S., Shamji, M. H., Ventura, M. T., Valiulis, A., Yorgancioglu, A., Matricardi, P., Zuberbier, T. and the ARIA-MASK Study Group (2020) 'Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement', Allergy. doi: 10.1111/all.14336
Link to publisher’s version
Copyright
© 2020, John Wiley & Sons, Inc. This is the peer reviewed version of the following article: Klimek, L., Jutel, M., Akdis, C., Bousquet, J., Akdis, M., Bachert, C., Agache, I., Ansotegui, I., Bedbrook, A., Bosnic-Anticevich, S., Canonica, G. W., Chivato, T., Cruz, A. A., Czarlewski, W., Giacco, S. D., Du, H., Fonseca, J. A., Gao, Y., Haahtela, T., Hoffmann-Sommergruber, K., Ivancevich, J. C., Khaltaev, N., Knol, E. F., Kuna, P., Larenas-Linnemann, D., Melen, E., Mullol, J., Naclerio, R., Ohta, K., Okamoto, Y., O'Mahony, L., Onorato, G. L., Papadopoulos, N. G., Pawankar, R., Pfaar, O., Samolinski, B., Schwarze, J., Toppila-Salmi, S., Shamji, M. H., Ventura, M. T., Valiulis, A., Yorgancioglu, A., Matricardi, P., Zuberbier, T. and the ARIA-MASK Study Group (2020) 'Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement', Allergy, doi: 10.1111/all.14336, which has been published in final form at https://doi.org/10.1111/all.14336. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.